Evidence map›Paper›PMID 29124353›Full record

ArticleBrain structure & function2018

Oligomer-prone E57K-mutant alpha-synuclein exacerbates integration deficit of adult hippocampal newborn neurons in transgenic mice.

Martin Regensburger, Sebastian R Schreglmann, Svenja Stoll, Edward Rockenstein, Sandra Loskarn, Wei Xiang, Eliezer Masliah, Beate Winner

Open access · hybridAbstract read
In one paragraph

Article in Brain structure & function, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Martin RegensburgerDepartment of Stem Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.ORCID http://orcid.org/0000-0002-2172-7386
Sebastian R SchreglmannSchool of Medicine, University of Regensburg, Regensburg, Germany.
Svenja StollDepartment of Stem Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Edward RockensteinDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Sandra LoskarnDepartment of Stem Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Wei XiangInstitute of Biochemistry, FAU, Erlangen, Germany.
Eliezer MasliahDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Beate WinnerDepartment of Stem Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. beate.winner@fau.de.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of California San Diego · USSobell House · GB

Funding

Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging populationZIAAG000936 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2017 to 2025
$4.1M
Bayerisches Staatsministerium für Wissenschaft, Forschung und Kunst Bavarian Research Network for induced pluripotent stem cells ForIPSBayerisches Staatsministerium für Wissenschaft, Forschung und Kunst (DE) BioSysNetBundesministerium für Bildung und Forschung 01EK1609BBundesministerium für Bildung und Forschung 01GM1520ABundesministerium für Bildung und Forschung 01GQ113Deutsche Forschungsgemeinschaft 410/45-1 FUGGDeutsche Forschungsgemeinschaft (DE) GRK2162IZKF, Universitätsklinikum Erlangen (DE) 14-03-12-1IZKF, Universitätsklinikum Erlangen (DE) J52IZKF, Universitätsklinikum Erlangen (DE) N3Universitätsklinikum Regensburg (DE) IRES Program
6 · The paper itself

Abstract

In the adult mammalian hippocampus, new neurons are constantly added to the dentate gyrus. Adult neurogenesis is impaired in several neurodegenerative mouse models including α-synuclein (a-syn) transgenic mice. Among different a-syn species, a-syn oligomers were reported to be the most toxic species for neurons. Here, we studied the impact of wild-type vs. oligomer-prone a-syn on neurogenesis. We compared the wild-type a-syn transgenic mouse model (Thy1-WTS) to its equivalent transgenic for oligomer-prone E57K-mutant a-syn (Thy1-E57K). Transgenic a-syn was highly expressed within the hippocampus of both models, but was not present within adult neural stem cells and neuroblasts. Proliferation and survival of newly generated neurons were unchanged in both transgenic models. Thy1-WTS showed a minor integration deficit regarding mushroom spine density of newborn neurons, whereas Thy1-E57K exhibited a severe reduction of all spines. We conclude that cell-extrinsic a-syn impairs mushroom spine formation of adult newborn neurons and that oligomer-prone a-syn exacerbates this integration deficit. Moreover, our data suggest that a-syn reduces the survival of newborn neurons by a cell-intrinsic mechanism during the early neuroblast development. The finding of increased spine pathology in Thy1-E57K is a new pathogenic function of oligomeric a-syn and precedes overt neurodegeneration. Thus, it may constitute a readout for therapeutic approaches.

Indexed as

alpha-SynucleinAnimalsBromodeoxyuridineCaspase 3Cell ProliferationDisease Models, AnimalDoublecortin Domain ProteinsGene Expression RegulationGlutamic AcidHippocampusLysineMiceMice, Inbred C57BLMice, TransgenicMicrotubule-Associated ProteinsMutationalpha-SynucleinBromodeoxyuridineCaspase 3Doublecortin Domain ProteinsGlutamic AcidLysineMicrotubule-Associated ProteinsNeuropeptidesPhosphopyruvate HydrataseSox2 protein, mouseSOXB1 Transcription FactorsAdult neurogenesisAlpha-synucleinHippocampusOligomers

Identifiers

PMID29124353
PMCPMC5869938
OpenAlexW2767957721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.